AMETEK, Inc. $AME Stake Trimmed by Guinness Asset Management LTD

Guinness Asset Management LTD cut its position in shares of AMETEK, Inc. (NYSE:AME) by 4.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 249,862 shares of the technology company’s stock after selling 12,041 shares during the quarter. Guinness Asset Management LTD’s holdings in AMETEK were worth $46,692,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the company. Darwin Wealth Management LLC purchased a new stake in shares of AMETEK in the 2nd quarter valued at approximately $25,000. NewSquare Capital LLC raised its stake in AMETEK by 129.7% during the 2nd quarter. NewSquare Capital LLC now owns 170 shares of the technology company’s stock valued at $31,000 after purchasing an additional 96 shares during the period. TruNorth Capital Management LLC acquired a new stake in shares of AMETEK in the third quarter worth $31,000. SouthState Corp grew its holdings in shares of AMETEK by 47.4% during the second quarter. SouthState Corp now owns 202 shares of the technology company’s stock valued at $37,000 after buying an additional 65 shares in the last quarter. Finally, AdvisorShares Investments LLC acquired a new position in AMETEK during the second quarter valued at $39,000. 87.43% of the stock is owned by hedge funds and other institutional investors.

AMETEK Price Performance

AMETEK stock opened at $229.63 on Friday. AMETEK, Inc. has a one year low of $145.02 and a one year high of $234.56. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.06 and a quick ratio of 0.72. The business has a 50 day simple moving average of $210.31 and a 200 day simple moving average of $195.30. The company has a market capitalization of $52.86 billion, a PE ratio of 35.88, a price-to-earnings-growth ratio of 3.09 and a beta of 1.03.

AMETEK (NYSE:AME) last posted its earnings results on Tuesday, February 3rd. The technology company reported $2.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.07. AMETEK had a net margin of 20.00% and a return on equity of 16.55%. The company had revenue of $2 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same quarter in the previous year, the company posted $1.87 earnings per share. AMETEK’s quarterly revenue was up 13.4% compared to the same quarter last year. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. On average, sell-side analysts forecast that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.

Insiders Place Their Bets

In other AMETEK news, VP Thomas M. Montgomery sold 6,388 shares of the stock in a transaction on Monday, December 22nd. The stock was sold at an average price of $205.05, for a total value of $1,309,859.40. Following the transaction, the vice president directly owned 22,116 shares in the company, valued at approximately $4,534,885.80. This trade represents a 22.41% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO David A. Zapico sold 88,000 shares of the business’s stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $196.39, for a total value of $17,282,320.00. Following the sale, the chief executive officer owned 348,955 shares of the company’s stock, valued at approximately $68,531,272.45. The trade was a 20.14% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 137,088 shares of company stock valued at $27,212,340. 0.57% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

AME has been the topic of several research analyst reports. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $257.00 target price on shares of AMETEK in a research note on Wednesday. Oppenheimer cut shares of AMETEK from an “outperform” rating to a “market perform” rating in a research note on Tuesday, January 27th. Truist Financial set a $265.00 target price on AMETEK in a research note on Wednesday. Melius Research set a $235.00 price target on shares of AMETEK in a report on Monday, January 5th. Finally, Morgan Stanley lifted their target price on AMETEK from $198.00 to $215.00 and gave the stock an “equal weight” rating in a research report on Monday, January 12th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $243.00.

Key Headlines Impacting AMETEK

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Q4 earnings beat and revenue growth — AMETEK reported Q4 results that topped estimates, with EPS and revenues up year-over-year and broad strength across both operating segments. AMETEK Q4 Earnings Surpass Expectations, Revenues Rise Y/Y
• Positive Sentiment: Record 2025 and earnings-call highlights — Management called out a record year (2025) and provided color on drivers, supporting the narrative of durable end-market demand and execution. AMETEK (AME) Earnings Call Highlights Record Year
• Positive Sentiment: LKC deal and strategic M&A tailwinds — Coverage notes the LKC acquisition and other niche-market deals as contributors to 2025 results and future addressable-market expansion. How Record 2025 Results and LKC Deal Will Impact AMETEK (AME) Investors
• Positive Sentiment: Analyst upgrades/target increases — KeyCorp raised its price target to $260 (overweight) and DA Davidson reaffirmed a buy with a $240 target, signaling dealer confidence that upside remains from current levels. Benzinga
• Positive Sentiment: New distribution partnership — Transcat will distribute and calibrate AMETEK’s programmable power supplies across the Americas, widening go-to-market reach for a product line that supports industrial and test customers. Transcat to distribute, calibrate Ametek Programmable Power supplies in Americas
• Neutral Sentiment: Growth opportunities vs. premium valuation — Coverage highlights AMETEK’s expansion into ophthalmic technologies as a growth vector but notes the stock is trading at a premium multiple, which could limit upside without continued execution. AMETEK Eyes Growth In Ophthalmic Tech While Valuation Stays Premium
• Neutral Sentiment: Acquisitions offset margin pressure — Analysis says acquisitions and niche-market expansion helped results but also flagged margin pressure; mixed implications for near-term profitability. AME Q4 deep dive: Acquisitions and niche market expansion offset margin pressure
• Negative Sentiment: Analyst caution — Morgan Stanley maintained a Hold and a $215 price target, reflecting concerns about margin durability and valuation that could cap near-term gains. Resilient Revenue and Margin Caution Keep Ametek at Hold

About AMETEK

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.